About Michael Mortlock
Form D filings for Stabilux Biosciences in 2024 list Michael Mortlock as executive officer.
Michael Mortlock first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Mortlock in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Mortlock works with at each company, as listed on that company's latest Form D.
Stabilux Biosciences, Inc. · Form D, May 16, 2024
JL
Jonathan Leinonen
Executive officer and director
YY
Yoke Yap
President and director
ME
Mark Ehlert
Director
ST
Steve Tokarz
Executive officer and director
JR
John Ransom
Director